title: Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
authors.affiliation: Surgical Research Laboratory, Harvard Medical School, Boston, MA.
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: L A
authors.initials: LA
authors.lastname: Turka
authors.forename: H
authors.initials: H
authors.lastname: Ueda
authors.forename: T
authors.initials: T
authors.lastname: Diamantstein
authors.forename: E L
authors.initials: EL
authors.lastname: Milford
authors.forename: C B
authors.initials: CB
authors.lastname: Carpenter
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
authors.forename: J W
authors.initials: JW
authors.lastname: Kupiec-Weglinski
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002478:Cells, Cultured; D006085:Graft Survival; D016027:Heart Transplantation; D007376:Interleukin-2 / Q000276:immunology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000637:transplantation; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D015375:Receptors, Interleukin-2